Elsevier

The Lancet

Volume 383, Issue 9925, 12–18 April 2014, Pages 1333-1354
The Lancet

Health Policy
Advancing social and economic development by investing in women's and children's health: a new Global Investment Framework

https://doi.org/10.1016/S0140-6736(13)62231-XGet rights and content

Summary

A new Global Investment Framework for Women's and Children's Health demonstrates how investment in women's and children's health will secure high health, social, and economic returns. We costed health systems strengthening and six investment packages for: maternal and newborn health, child health, immunisation, family planning, HIV/AIDS, and malaria. Nutrition is a cross-cutting theme. We then used simulation modelling to estimate the health and socioeconomic returns of these investments. Increasing health expenditure by just $5 per person per year up to 2035 in 74 high-burden countries could yield up to nine times that value in economic and social benefits. These returns include greater gross domestic product (GDP) growth through improved productivity, and prevention of the needless deaths of 147 million children, 32 million stillbirths, and 5 million women by 2035. These gains could be achieved by an additional investment of $30 billion per year, equivalent to a 2% increase above current spending.

Introduction

Substantial reductions in maternal and child deaths have been achieved worldwide in the last two decades. The global maternal mortality ratio reduced by 47% in 1990–2010 and the under-5 mortality reduced by 47% in 1990–2012.1, 2 However, this falls short of the rates of reduction needed by 2015 to achieve the Millennium Development Goals (MDGs) 4 and 5. Despite rapid economic growth in many Asian countries, south Asia still accounts for a third of child and maternal mortality (appendix). Communicable, maternal, neonatal, and nutritional causes account for 25% of deaths and remain dominant causes of premature mortality in sub-Saharan Africa.3 Maternal causes are a significant cause of death for women aged 15–34 years, accounting for 11% of deaths in 2010.3

Sustained global and regional efforts are being made to support countries to accelerate progress, including the UN Secretary-General's Global Strategy for Women's and Children's Health, and the Campaign on Accelerated Reduction of Maternal, Newborn and Child Mortality in Africa.4, 5, 6, 7 As part of these initiatives, much work has been done to calculate where additional investment is needed to improve health systems and service delivery in low-income countries.8, 9 Our analysis builds on this work, with particular focus on the substantial social and economic benefits that can accrue when a country invests in the health of its women and children.

The investment gaps are well known: insufficiently resourced health systems10 with low coverage of cost-effective interventions,11 and poor health information and management systems,12 making inefficient use of limited resources.13 This in turn leads to unacceptably high rates of preventable maternal and child deaths with significant social and economic losses.

The leading causes of maternal mortality—obstetric haemorrhage, hypertensive disorders of pregnancy, sepsis, and unsafe abortion14—are, to a large extent, preventable in most high-burden countries. Death from these causes can usually be prevented by well equipped health facilities, the presence of a skilled care provider (even at the lowest level of the health system), a functioning referral system, and a reliable supply of life-saving commodities. Some services are key interventions to prevent maternal deaths, such as contraception, antenatal care, skilled birth attendance, integrated reproductive health care in the postnatal phase, postnatal care, and a range of services for adolescents and women. However, access to them remains low, especially among the poorest in high-burden countries.15

Key messages

  • Additional investments of US$5 per person per year in 74 countries, with 95% of the global maternal and child mortality burden, would yield high rates of return, producing up to nine times the economic and social benefit by 2035.

  • Continuing historical trends of coverage increases is not sufficient. Accelerated investments are needed to bring health benefits to the majority of women and children.

  • Compared with current trends, our accelerated investment scenario estimates that a total of 5 million maternal deaths, 147 million child deaths, and 32 million stillbirths can be prevented in 2013–35 in 74 high-burden countries.

  • Expanding access to contraception will be a particularly cost-effective investment potentially accounting for half of all the deaths prevented in the accelerated investment scenario.

  • More than a third of the additional costs required are health systems investments that are also required for services beyond those for reproductive, maternal, newborn, and child health. An ambitious scale-up would require an additional 675 000 nurses, doctors, and midwives in 2035, along with 544 000 community health workers.

  • The new global investment framework could serve as a guide to countries to optimise investments in women's and children's health within national health and development plans over the next two decades.

Health systems investments are also required to prevent child mortality. WHO has estimated that 17% of deaths in children younger than 5 years are due to diseases that can be prevented by routine, cost-effective vaccination.16 Although coverage rates of immunisation are high compared with other maternal and child health interventions, many children still die from easily preventable diseases, including pneumonia and diarrhoea.17 New pneumococcal and rotavirus vaccines now exist to prevent these disorders. Coverage can be scaled up by strengthening existing supply chains and by training health workers to provide integrated care at facilities, and through outreach activities to rural communities. Robust health information systems and good management are also needed to ensure efficient and effective immunisation coverage.

High rates of malnutrition underlie more than 45% of all deaths in children younger than 5 years and are a significant factor in maternal mortality. For those children who survive, malnutrition jeopardises their potential for optimum growth and development, with important consequences later in life.18, 19

The economic and social consequences of poor health services coverage and outcomes to families and communities are substantial, particularly for the poor and other vulnerable groups.20, 21 Unexpected illness and associated health-care costs are leading causes of impoverishment in many low-income and middle-income countries.22 Poor health has a detrimental effect on school attendance and performance and future earnings.23 Children—not just newborn babies—whose mothers die, are, on average, more likely to die before the age of 2 years than children with mothers.24 If they do survive, they are also disadvantaged socially and economically.25

The analysis in this study estimates the costs and benefits of addressing the remaining gaps through health sector interventions. We show the potential effect on the economy and outline benefits for overall development.

In response to a recommendation in 2012 by the UN independent Expert Review Group on information and accountability for women's and children's health (iERG), WHO, the Partnership for Maternal, Newborn & Child Health (PMNCH), and The Lancet Commission on Investing in Health26 coordinated the development of a global investment framework for women's and children's health (“the investment framework”).27 This builds on the HIV/AIDS investment framework and previous investment cases for reproductive, maternal, newborn, and child health (RMNCH) and other initiatives.9, 28, 29, 30, 31 (appendix).

We have undertaken a new analysis that extends the earlier work by estimating the effects of investment on RMNCH across the continuum of care, including family planning, stillbirths, and newborn health (which have not always been included in previous studies). It also extends the timeframe to 2035 (this end date was chosen to align our analysis with the The Lancet Commission on Investing in Health) and analyses the economic and social returns on investment. The findings of this analysis will contribute to broader policy dialogue on effective health investments, including by being an input to The Lancet Commission on Investing in Health, which is expected to publish its report in December, 2013.

The analysis provides an updated estimate of the health, social, and economic benefits of investing in strengthening health systems to deliver RMNCH interventions in 74 low-income and middle-income countries that account for more than 95% of maternal and child deaths. It provides a global cost estimate of the level of investment required for the integrated delivery of a set of evidence-based RMNCH interventions. In modelling investment needs and health outcomes, the analysis supports an implementation approach that factors in equity and the social determinants of health—ie, by considering the effect of conditional cash transfers on increasing the proportion of women giving birth in health facilities. While recognising the intrinsic value of health and its role in meeting basic human rights, it also attempts to estimate the economic benefits of averting morbidity and mortality. This study analyses the broader, long-term health and nutrition gains to human capital development, and the substantial benefits of family planning for both health outcomes and socioeconomic development. The framework also emphasises the broader links to, and need for, health systems strengthening.

Section snippets

Conceptual framework

We first developed a conceptual framework that underpins the development of the Global Investment Framework for Women's and Children's Health (figure 1). This starts with the overall health and development context, and within it identifies four broad dimensions or “key enablers” that drive health outcomes: policy, health system, community engagement, and innovation. These enablers are key to scaling up essential interventions in a way that is politically, financially, technically, and socially

Health impact of additional investments

The modelling suggests that increased and improved coverage of essential RMNCH interventions, through additional investments, could significantly reduce mortality in the 74 countries. The high coverage scenario would result in 147 million fewer child deaths, 32 million fewer stillbirths, and 5 million fewer maternal deaths between 2013 and 2035 (appendix). Substantial reductions in the total fertility rate (figure 3), under-5 mortality (figure 4A), maternal mortality ratio (figure 4B) and

Discussion

The new Global Investment Framework for Women's and Children's Health presented in this paper points to five important findings for policy makers.

First, health interventions and family planning can result in substantial health benefits and reductions in mortality and morbidity. Compared with current investment levels, our high scenario estimates that 5 million maternal deaths, 147 million child deaths, and 32 million stillbirths can be prevented in 2013–35 in 74 Countdown countries that

Conclusion

We present a new global investment framework which makes the case for accelerated and targeted investment. With increased coverage of life-saving interventions across the continuum of care, rapid and sustained progress in RMNCH outcomes is achievable in a wide range of country settings across the globe. Experience from countries as varied as Bangladesh, Cambodia, Ethiopia, Rwanda, and Turkey show that coverage of reproductive, maternal, and child health interventions can indeed be scaled up

References (92)

  • AJD Barros et al.

    Equity in maternal, newborn, and child health interventions in Countdown to 2015: a retrospective review of survey data from 54 countries

    Lancet

    (2012)
  • K Xu et al.

    Household catastrophic health expenditure: a multicountry analysis

    Lancet

    (2003)
  • C Ronsmans et al.

    Effect of parent's death on child survival in rural Bangladesh: a cohort study

    Lancet

    (2010)
  • B Schwartländer et al.

    Towards an improved investment approach for an effective response to HIV/AIDS

    Lancet

    (2011)
  • RE Black et al.

    Maternal and child nutrition: building momentum for impact

    Lancet

    (2013)
  • J Borghi et al.

    Mobilising financial resources for maternal health

    Lancet

    (2006)
  • GL Darmstadt et al.

    Evidence-based, cost-effective interventions: how many newborn babies can we save?

    Lancet

    (2005)
  • J Bryce et al.

    Can the world afford to save the lives of 6 million children each year?

    Lancet

    (2005)
  • ZA Bhutta et al.

    Stillbirths: what difference can we make and at what cost?

    Lancet

    (2011)
  • ZA Bhutta et al.

    Interventions to address deaths from childhood pneumonia and diarrhoea equitably: what works and at what cost?

    Lancet

    (2013)
  • N Walker et al.

    Patterns in coverage of maternal, newborn, and child health interventions: projections of neonatal and under-5 mortality to 2035

    Lancet

    (2013)
  • P Travis et al.

    Overcoming health-systems constraints to achieve the Millennium Development Goals

    Lancet

    (2004)
  • R Fryatt et al.

    Financing of health systems to achieve the health Millennium Development Goals in low-income countries

    Lancet

    (2010)
  • LH Bearinger et al.

    Global perspectives on the sexual and reproductive health of adolescents: patterns, prevention, and potential

    Lancet

    (2007)
  • JP Souza et al.

    Moving beyond essential interventions for reduction of maternal mortality (the WHO Multicountry Survey on Maternal and Newborn Health): a cross-sectional study

    Lancet

    (2013)
  • MK Mwaniki et al.

    Long-term neurodevelopmental outcomes after intrauterine and neonatal insults: a systematic review

    Lancet

    (2012)
  • T Vos et al.

    Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

    Lancet

    (2012)
  • CG Victora et al.

    Maternal and child undernutrition: consequences for adult health and human capital

    Lancet

    (2008)
  • J Hsu et al.

    Countdown to 2015: changes in official development assistance to maternal, newborn, and child health in 2009–10, and assessment of progress since 2003

    Lancet

    (2012)
  • J Hsu et al.

    Reproductive health priorities: evidence from a resource tracking analysis of official development assistance in 2009 and 2010

    Lancet

    (2013)
  • SJ Goldie et al.

    Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries

    Vaccine

    (2008)
  • R Atun et al.

    Universal health coverage in Turkey: enhancement of equity

    Lancet

    (2013)
  • Trends in maternal mortality: 1990 to 2010

    (2012)
  • WHO, World Bank, UN DESA/Population Division. Levels and trends in child mortality—report 2013. estimates developed by the UN Inter-agency Group for Child Mortality Estimation

  • United Nations Global Strategy for Women's and Children's Health

  • Every woman every child

  • A new global partnership: eradicate poverty and transform economies through sustainable development. The report of the High-Level Panel of Eminent Persons on the Post-2015 Development Agenda

  • Campaign on accelerated reduction of maternal, newborn and child mortality in Africa

  • WHO. Commission on Macroeconomics and Health. (2001) Macroeconomics and health: investing in health for economic...
  • Constraints to scaling up and costs: Working Group 1 Report

  • Countdown to 2015. Accountability for maternal, newborn and child survival: the 2013 update

  • WHO Immunization surveillance, assessment and monitoring: vaccine preventable diseases

  • JP Ruger et al.

    Health and the economy

  • State of the World's Children 2009: maternal and newborn health

    (2009)
  • The World Bank's World Development Report 1993 @ 20 Years

  • Every woman, every child: from commitments to action. The first report of the independent Expert Review Group (iERG) on information and accountability for women's and children's health

  • Study Group members listed at the end of the paper

    View full text